EUVIMEDDescubrir EUVIMED
Qualitative StudieStudienprotokollOpen access

Digital Health Tool for Preventing Blindness From Diabetic Retinopathy: Protocol for a Qualitative Study

Akua Frimpong iD, Alvaro Granados iD, Thomas Chang iD, Julia Fu iD, Serina S Applebaum iD, Shannan G Moore iD, Mahima Kaur iD, Bolatito Adepoju iD, Vignesh Hari Krishnan iD, Amanda Levi iD, Terika McCall iD, Kristen Harris Nwanyanwu iD

JMIR Research Protocols · 2025

DOI: 10.2196/65894 ↗

At a glance

Qualitative Studie in JMIR Research Protocols, 2025. Written by Akua Frimpong and 11 co-authors. Institution: Department of Ophthalmology and Visual Science, Yale School of Medicine, New Haven, CT, United States. Major MEDLINE topics: Diabetic Retinopathy, Blindness. 41 references. The full text is freely available in PubMed Central. Funded by: NEI NIH HHS, NIDDK NIH HHS.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Background

Diabetic retinopathy (DR), a leading cause of preventable blindness among working-age adults, leads to worse health outcomes among Black, Latine, and individuals with lower income in comparison to other ethnic, racial, and socioeconomic groups in the United States.

Objective

We aim to engage community members directly to identify barriers and facilitators of DR screening and co-design a digital health tool that is accessible, user-friendly, and community-responsive.

Methods

We conducted focus groups with individuals from the Greater New Haven, Connecticut area, aged 18 years or older, and diagnosed with diabetes to (1) conduct a comprehensive disease-management needs assessment and (2) inform the development of a community-responsive digital health tool to optimize DR education and to increase access to DR screening in high-risk populations. We transcribed the focus group interviews, used rapid qualitative analysis to generate themes, and completed affinity mapping to identify content and features for a digital health tool for preventing blindness from DR.

Results

We recruited and interviewed 19 individuals (13/19, 68% female; 9/19, 47% Black; 5/19, 26% Hispanic; 2/19, 11% Native American or Alaska Native) for 4 focus groups. Over 94% (18/19) had access to smart devices other than a computer. Participants self-reported mean hemoglobin A1c of 6.77 (SD 1.93). Approximately 58% (11/19) of the participants completed some college. Frequently occurring themes (>30) obtained from coding contextual interviews were desired app attributes such as options for customization, covering topics such as, the mental impact of living with diabetes, informal support (eg, peer support), diabetes education, barriers to controlling blood sugar and maintenance of health, dietary guidance, and notifications. We created high-fidelity wireframes incorporating key features. Next, we will iteratively design a prototype with community feedback.

Conclusions

We anticipate that this study will characterize the experiences of people living with diabetes. Using a community-led approach,we will continue to analyze the data that will generate insights regarding the key features, content, and benefits that are most important for the creation of a digital health tool for DR prevention. International Registered Report Identifier (IRRID) DERR1-10.2196/65894

Subjects

MeSH terms (MEDLINE)

Diabetic RetinopathyBlindnessHumansQualitative ResearchFocus GroupsFemaleMaleAdultMiddle AgedAgedTelemedicineMass ScreeningDigital Health

Author keywords

DMblindnesscommunity engagementcommunity-leddiabetes mellitusdiabetic retinopathydigital health tooldigital toolmHealthmobile appsmobile healthpreventable blindnesspreventionqualitative studyuser-centered design

Authors and institutions

  • Department of Ophthalmology and Visual Science, Yale School of Medicine, New Haven, CT, United States.
  • Larner College of Medicine at University of Vermont School of Medicine, Burlington, VT, United States.
  • Kaiser Permanente Bernard J Tyson School of Medicine, Pasadena, CA, United States.
  • Division of Health Informatics, Department of Biostatistics, Yale School of Public Health, New Haven, CT, United States.
  • Department of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, CT, United States.

ORCID profiles: Akua Frimpong, Alvaro Granados, Thomas Chang, Julia Fu, Serina S Applebaum, Shannan G Moore, Mahima Kaur, Bolatito Adepoju, Vignesh Hari Krishnan, Amanda Levi, Terika McCall, Kristen Harris Nwanyanwu

Funding

  • NEI NIH HHS
  • NIDDK NIH HHS

Cite

APA

Frimpong, A., Granados, A., Chang, T., Fu, J., Applebaum, S. S., Moore, S. G., Kaur, M., Adepoju, B., Hari Krishnan, V., Levi, A., McCall, T., & Nwanyanwu, K. H. (2025). Digital Health Tool for Preventing Blindness From Diabetic Retinopathy: Protocol for a Qualitative Study. JMIR Research Protocols. https://doi.org/10.2196/65894

Vancouver

Frimpong A, Granados A, Chang T, Fu J, Applebaum SS, Moore SG, et al. Digital Health Tool for Preventing Blindness From Diabetic Retinopathy: Protocol for a Qualitative Study. JMIR Research Protocols. 2025. doi:10.2196/65894

BibTeX
@article{Frimpong2025,
  author = {Frimpong, Akua and Granados, Alvaro and Chang, Thomas and Fu, Julia and Applebaum, Serina S and Moore, Shannan G and Kaur, Mahima and Adepoju, Bolatito and Hari Krishnan, Vignesh and Levi, Amanda and McCall, Terika and Nwanyanwu, Kristen Harris},
  title = {Digital Health Tool for Preventing Blindness From Diabetic Retinopathy: Protocol for a Qualitative Study},
  journal = {JMIR Research Protocols},
  year = {2025},
  doi = {10.2196/65894}
}
Start for free →